当前位置: 首页 > 新闻资讯 > 产品文献 > "酶免"产品文献：MSC-exosomes pretreated by Danshensu extracts pretreating to target the hsa-miR-27a-5p and STAT3-SHANK2 to enhanced antifibrotic therapy

"酶免"产品文献：MSC-exosomes pretreated by Danshensu extracts pretreating to target the hsa-miR-27a-5p and STAT3-SHANK2 to enhanced antifibrotic therapy

酶免官方商城 / 2026-03-26

文献标题

MSC-exosomes pretreated by Danshensu extracts pretreating to target the hsa-miR-27a-5p and STAT3-SHANK2 to enhanced antifibrotic therapy

文献作者

Jiabin Liang、Jingxiu Zhao、Lin Yang、Qian Wang、Jing Liao、Jianhao Li、Weizhao Zhuang、Fanghong Li、Jinxian He、Yukuan Tang、Hanwei Chen、Chen Huang

发表时间

2025年02月04日

文献影响因子

7.1

使用的酶免科研试剂盒产品名称

人白细胞介素8（IL-8）ELISA科研试剂盒

人白细胞介素2（IL-2）ELISA科研试剂盒

人白细胞介素6（IL-6）ELISA科研试剂盒

下一篇:"酶免"产品文献：A classic prescription alleviates inflammation in CUMS model mice via modulating MYDGF/MAP4K4/NF-κB signaling pathway, verified through UPLC-HRMS and proteomics analysis
上一篇:"酶免"产品文献：Multi-omics analysis provides new insights into the molecular mechanisms underlying colostral immunoglobulin G absorption in the gut of neonatal goat kids

全部产品分类

浏览历史

"酶免"产品文献：MSC-exosomes pretreated by Danshensu extracts pretreating to target the hsa-miR-27a-5p and STAT3-SHANK2 to enhanced antifibrotic therapy